Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novartis, Amgen halt Alzheimer’s clinical programme with BACE1 inhibitor
Image: Novartis and Amgen have stopped Alzheimer’s clinical programme with BACE1 inhibitor. Photo: courtesy of Novartis AG.
Image: Novartis and Amgen have stopped Alzheimer’s clinical programme with BACE1 inhibitor. Photo: courtesy of Novartis AG.